http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0216588-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5630ca75e1764e840ffe691436555575 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 |
| filingDate | 2001-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c362716380f6bc45055f83bd180bc46 |
| publicationDate | 2002-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0216588-A2 |
| titleOfInvention | 15985, a human serine/threonine protein kinase family membe r and uses thereof |
| abstract | The invention provides isolated nucleic acids molecules, designated 15985 nucleic acid molecules, which encode novel serine/threonine protein kinase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 15985 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 15985 gene has been introduced or disrupted. The invention still further provides isolated 15985 proteins, fusion proteins, antigenic peptides and anti-15985 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0231129-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0231129-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6610537-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03018816-A1 |
| priorityDate | 2000-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1031.